Cost-Effectiveness Analysis of Risk-Reduction Strategies

Blood Safety and Surveillance ◽

10.1201/b13998-24 ◽

2001 ◽

pp. 521-542

Author(s):

James AuBuchon

Keyword(s):

Cost Effectiveness ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Reduction Strategies ◽

Risk Reduction Strategies

Download Full-text

Cost-Effectiveness Analysis of Risk- Reduction Strategies

Blood Safety and Surveillance ◽

10.1201/9780203908242.ch23 ◽

2001 ◽

Author(s):

James AuBuchon

Keyword(s):

Cost Effectiveness ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Reduction Strategies ◽

Risk Reduction Strategies

Download Full-text

Cost-Effectiveness Analysis of Risk-Reduction Strategies

Blood Safety and Surveillance ◽

10.3109/9780203908242-25 ◽

2001 ◽

pp. 535-556

Keyword(s):

Cost Effectiveness ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Reduction Strategies ◽

Risk Reduction Strategies

Download Full-text

Cost-Effectiveness Analysis of Cancer Risk Reduction Strategies for BRCA Mutation Carriers

Value in Health ◽

10.1016/j.jval.2016.09.2226 ◽

2016 ◽

Vol 19 (7) ◽

pp. A736

Author(s):

OS Khodorovich ◽

VA Solodkiy ◽

EV Derkach

Keyword(s):

Cost Effectiveness ◽

Cancer Risk ◽

Risk Reduction ◽

Brca Mutation ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Reduction Strategies ◽

Brca Mutation Carriers ◽

Risk Reduction Strategies ◽

Cancer Risk Reduction

Download Full-text

Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States

PLoS ONE ◽

10.1371/journal.pone.0116694 ◽

2015 ◽

Vol 10 (2) ◽

pp. e0116694 ◽

Cited By ~ 4

Author(s):

Dahye L. Song ◽

Frederick L. Altice ◽

Michael M. Copenhaver ◽

Elisa F. Long

Keyword(s):

United States ◽

Cost Effectiveness ◽

Risk Reduction ◽

People Who Inject Drugs ◽

The United States ◽

Cost Effectiveness Analysis ◽

Evidence Based ◽

Infected People ◽

Effectiveness Analysis

Download Full-text

PCV114 FEASIBILITY OF USING REAL WORLD EVIDENCE TO INFORM DECISIONS ON CONDUCTING A COST EFFECTIVENESS ANALYSIS: AN EXAMPLE OF STROKE RISK REDUCTION THERAPIES IN ATRIAL FIBRILLATION

Value in Health ◽

10.1016/j.jval.2019.09.838 ◽

2019 ◽

Vol 22 ◽

pp. S563

Author(s):

O. Saunders ◽

R.L. Akehurst ◽

Y. Zhong ◽

S.L. Amorosi ◽

M. Gavaghan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Risk Reduction ◽

Real World ◽

Stroke Risk ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Real World Evidence

Download Full-text

Cost-effectiveness analysis of risk-reduction measures to reach water safety targets

Water Research ◽

10.1016/j.watres.2010.07.048 ◽

2011 ◽

Vol 45 (1) ◽

pp. 241-253 ◽

Cited By ~ 15

Author(s):

Andreas Lindhe ◽

Lars Rosén ◽

Tommy Norberg ◽

Olof Bergstedt ◽

Thomas J.R. Pettersson

Keyword(s):

Cost Effectiveness ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Water Safety ◽

Effectiveness Analysis ◽

Risk Reduction Measures

Download Full-text

A Cost-Effectiveness Analysis of Venom Desensitization in Children Treated for Cure and Risk-Reduction

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2005.12.1219 ◽

2006 ◽

Vol 117 (2) ◽

pp. S309

Author(s):

K.F. Brown ◽

M.S. Shaker ◽

P.C. Jenkins ◽

M.S. Verdi

Keyword(s):

Cost Effectiveness ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction

Surgery ◽

10.1016/j.surg.2016.06.062 ◽

2017 ◽

Vol 161 (1) ◽

pp. 16-24 ◽

Cited By ~ 25

Author(s):

Kyle A. Zanocco ◽

James X. Wu ◽

Michael W. Yeh

Keyword(s):

Cost Effectiveness ◽

Primary Hyperparathyroidism ◽

Fracture Risk ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Fracture Risk Reduction ◽

Asymptomatic Primary Hyperparathyroidism

Download Full-text

PCN71 COST EFFECTIVENESS ANALYSIS OF BREAST CANCER RISK REDUCTION THERAPY: COMPARING TAMOXIFEN AND RALOXIFENE

Value in Health ◽

10.1016/s1098-3015(10)72160-4 ◽

2010 ◽

Vol 13 (3) ◽

pp. A37

Author(s):

JL Poon ◽

J Hay

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Breast Cancer Risk ◽

Cancer Risk ◽

Risk Reduction ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Breast Cancer Risk Reduction ◽

Cancer Risk Reduction

Download Full-text

Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

Clinical Pharmacology & Therapeutics ◽

10.1016/s0009-9236(96)90060-0 ◽

1996 ◽

Vol 60 (3) ◽

pp. 332-340 ◽

Cited By ~ 57

Author(s):

M DEGATTA ◽

M CALVO ◽

J HERNANDEZ ◽

D CABALLERO ◽

J SANMIGUEL ◽

...

Keyword(s):

Cost Effectiveness ◽

Hematologic Malignancies ◽

Cost Effectiveness Analysis ◽

Vancomycin Concentration ◽

Effectiveness Analysis ◽

Serum Vancomycin

Download Full-text